Congenital FVII deficiency and pulmonary embolism: A critical appraisal of all reported cases

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 1, 2013, Pages 55-59

  Girolami, A ^a   De Marinis, G Berti ^a   Vettore, S ^a   Girolami, B ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Padua City Hospital   (Italy)

Author keywords

FVII deficiency; pulmonary embolism; replacement therapy

Indexed keywords

BLOOD CLOTTING FACTOR 7; HEPARIN; PROTHROMBIN COMPLEX; WARFARIN;

ADULT; AGED; ALLELE; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HUMAN; LUNG EMBOLISM; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SUBSTITUTION THERAPY; THROMBOSIS;

CASE-CONTROL STUDIES; FACTOR VII DEFICIENCY; FEMALE; HUMANS; MALE; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 84871558345     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611436196     Document Type: Article

References (34)

1. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol. 2006 ; 116 (2). 120-125
2. Franchini M. Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost. 2004 ; 92 (2). 298-304
3. Girolami A, Tezza F, Scapin M, Vettore S, Casonato A. Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature. J Thromb Thrombolysis. 2006 ; 21 (2). 175-178
4. Mariani G, Herrmann FH, Schulman S, et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost. 2003 ; 1 (10). 2153-2158
5. Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia. 2006 ; 12 (4). 345-351
6. Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis. 2010 ; 30 (2). 172-178
7. Marty S, Barro C, Chatelain B, et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia. 2008 ; 14 (3). 564-570
8. Girolami A, Candeo N, Bonamigo E, Fabris F. Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. Eur J Haematol. 2011 ; 87 (1). 92-94
9. Girolami A, Brunetti A, Cella G, Bareggi G, Virgolini L, Cafiero F. La ipoproconvertinemia. Biol Lat. 1972 ; 23 (4). 391-434
10. Sabharwal AK, Kuppuswamy MN, Foster DC, et al. Factor VII deficiency (Factor VII Richmond, R304Q Mutant) associated with thrombosis. Circulation. 1992 ; 86: 679
11. Girolami A, Bertozzi I, Rigoni I, Muzzolon R, Vettore S. Bilateral pulmonary embolism in a patient with FVII Padua (Arg304Gln) after activated FVII concentrate substitution therapy for hysterectomy. J Thromb Thrombol. 2011 ; 32 (3). 362-367
12. Arellano-Rodrigo E, Gironella M, Nicolau I, Vila M. Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases. Thromb Haemost. 2009 ; 101 (2). 402-404
13. Barnett JM, Demel KC, Mega AE, Butera JN, Sweeney JD. Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol. 2005 ; 78 (2). 134-137
14. Gershwin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med. 1973 ; 288 (3). 141-142
15. Godal HC, Madsen K, Meyer RN. Thrombo-embolism in patients with total proconvertin (factor VII) deficiency. A report on two cases. Acta Med Scand. 1962 ; 171 (3). 325-327
16. Hall CA, Rapaport SI, Ames SB, DeGroot JA. A clinical and family study of hereditary proconvertin (Factor VII) deficiency. Am J Med. 1964 ; 37 (8). 172-181
17. Heikinheimo R, Reinikainen M. Congenital factor VII deficiency. Two cases in children of cousins. Thromb Diath Haemorrh. 1969 ; 21 (2). 245-248
18. Shifter T, Machtey I, Creter D. Thromboembolism in congenital factor VII deficiency. Acta Haematol. 1984 ; 71 (1). 60-62
19. Solanki DL, Corn M. Thromboembolism in patients with hereditary deficiency of coagulation factors. South Med J. 1980 ; 73 (7). 944-946
20. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII-a critical appraisal. Haemophilia. 2006 ; 12 (1). 19-27
21. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006 ; 295 (3). 293-298
22. Witmer CM, Huang YS, Lynch K, Raffini LJ, Shah SS. Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr. 2011 ; 158 (5). 820-825
23. Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Int Med. 2011 ; 154 (8). 516-522
24. Patiroflu T, Karakukcu M. Middle cerebral arterial thrombosis in a patient with hypofibrinogenemia, 5 days after rFVIIa and FFP infusion. Clin Appl Thromb Hemost. 2006 ; 12 (1). 111-113
25. O'Connell NM, Ridotell AF, Pascoe G, Perry DI, Lee CA. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Hemophilia. 2008 ; 14 (4). 775-781
26. Girolami A, Fabris F, Dal Bo, Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med. 1978 ; 91 (3). 387-395
27. Kirkel D, Lin TW, Fu SW, et al. Asymptomatic factor VII deficiency: gene analysis and structure-function relationships. Blood Coagul Fibrinolysis. 2010 ; 21 (1). 91-94
28. Perry DJ. Factor VII deficiency. Br J Haematol. 2002 ; 118 (3). 689-700
29. Herrmann FH, Wulff K, Auerswald G, et al. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009 ; 15 (1). 267-280
30. Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood. 1985 ; 66 (6). 1284-1287
31. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VIIPadua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta. 1993 ; 1172 (3). 301-305
32. Girolami A, Bonamigo E, Vettore S. The lack of ties between north-eastern Italy and African-Americans suggest a multi-founder effect for FVII Padua (Arg304Gln) disorder. Blood Coagul Fibrinolysis. 2010 ; 21 (8). 775-776
33. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304 - >Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem. 1994 ; 269 (10). 7355-7363
34. Girolami A, Candeo N, Vettore S, Lombardi AM, Girolami B. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis. 2010 ; 29 (3). 299-302